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Abstract: The objective of this study was to evaluate the anaesthetic effects on young hamadryas baboons (Papio hamadryas) of
xylazine–ketamine (XK) compared to diazepam–ketamine (DK). Six healthy young male hamadryas baboons were first premedicated
with xylazine HCl (0.5 mg/kg, IM) and anaesthetised 20 min later with ketamine (10 mg/kg, IM). After a 10-day washout period, the
hamadryas baboons were premedicated with diazepam (1 mg/kg, IM) and anaesthetised 20 min later with ketamine (10 mg/kg, IM).
The onset, duration, and the depth of anaesthesia were determined by recording palpebral, corneal, and jaw reflexes. The results showed
a significant decrease in heart rate and rectal temperature after XK injection, while a significant reduction in respiratory rate was seen
when using the DK protocol. A highly significant increase in the levels of glucose was observed with the XK regimen. Blood pressure
decreased when using both anaesthetic regimens, but this reduction did not reach significant levels. The quality of recovery was better
when using XK compared to DK. In conclusion, major complications including bradycardia, hypothermia, and hyperglycaemia should
be considered with a combination of XK. However, no complications other than bradypnea and hypercapnia should be expected when
immobilising young hamadryas baboons with DK. No significant difference was observed in CBC, electrolytes, or lactate level between
the anaesthesia protocols.
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1. Introduction
The wide range of body size and weight of nonhuman
primates plays an important role in the selection of an
appropriate anaesthetic agent and the dosage of the drug to
be administered. Primate species differ in their responses
to certain anaesthetic agents. Several studies have used
young nonhuman primates as experimental animal
models for human paediatric research (1–4). Baboons are
the largest old world nonhuman primates. Five species
of baboons (genus Papio) have been identified; four are
considered savanna baboons and the remaining one is
referred to as a desert baboon (5). The hamadryas baboon
(Papio hamadryas) or desert baboon is a common species
found in many countries including Saudi Arabia, Somalia,
Ethiopia, and Yemen (5). Weaning begins at 6 months and
the young become independent at 2 years of age. Males
and females reach sexual maturity at 4–7 and 4–5 years
old, respectively (5). Baboons are frequently utilised as
experimental animal models for a wide variety of research
in humans such as in studies of coronary heart disease,
* Correspondence: madehsadan@vet.svu.edu.eg

40

chronic lung disease, atherosclerosis, hypertension,
osteoporosis, and spinal disorders, and for development
of HIV and hepatitis C vaccines as well as for neonatal
research (5–8).
Injectable anaesthesia is preferred for conducting shortterm experiments with baboons. Ketamine, a short-acting
dissociative anaesthetic, has a wide margin of safety in
many species of nonhuman primates and has been used for
restraining and induction of anaesthesia in various species
including primates. However, poor muscular relaxation and
tonic–clonic movements or psychotomimetic emergence
reactions are associated with ketamine administration
in nonhuman primates (9–11). Thus, in order to achieve
complete immobilisation and reduce the undesirable
effects of injecting ketamine alone, administration of a
premedication agent in combination with the ketamine
is recommended. Xylazine (α2 adrenoceptor agonist)
and diazepam (benzodiazepine agent) have been used
widely as premedication drugs given with or prior to
ketamine administration in animals, including nonhuman
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primates (12–18). The administration of xylazine provides
the added effects of increased sleep time, good muscle
relaxation, prevention of voluntary muscle movement,
and substantial analgesia (19). Diazepam has been used
in combination with ketamine in hamadryas baboon for
minor procedures requiring muscle relaxation (16). To
the best of the authors’ knowledge, the effects of xylazine,
diazepam, and ketamine have not previously been studied
using young hamadryas baboons. Therefore, the aim of
the present study was to evaluate the anaesthetic effects
of xylazine–ketamine (XK) in young hamadryas baboons
(Papio hamadryas) and compare them with the effects of a
diazepam–ketamine (DK) regimen.
2. Materials and methods
The experimental protocol was approved by the Ethics
Committee (No. 367) for Animal Research of the Scientific
Research Deanship, Qassim University, Saudi Arabia
2.1. Hamadryas baboons
Six young male hamadryas baboons (Papio hamadryas)
were used in this study. These hamadryas baboons were
considered healthy on the basis of a physical examination.
Their mean body weight was 3.4 kg (range = 3–3.8) and
their mean age was 11 months (range = 10–12 months).
Food (fruits and vegetables) and water were withheld for 6
h before the beginning of the study. The experiments were
performed in a temperature-controlled room maintained
at 25 °C.
2.2. Anaesthesia
Twenty-gauge intravenous catheters (Mais Co., Riyadh,
Saudi Arabia) were placed in the left or right cephalic vein.
Combinations of XK and DK were administered with
a washout period of 10 days between the 2 anaesthetic
protocols. The hamadryas baboons were first premedicated
with xylazine HCl (0.5 mg/kg, IM, Rompun 2%, Bayer
Health Care, Monheim, Germany). Twenty minutes later,
general anaesthesia was induced with ketamine (10 mg/
kg, IM, ketamine 10%, Alfasan, Woerden, Holland). After
10 days, the hamadryas baboons were premedicated with
diazepam (1 mg/kg, IM, Valium, F. Hoffmann La Roche
Ltd., Basel, Switzerland) and anaesthetised 20 min later
with ketamine (10 mg/kg, IM).
The onset and duration of anaesthesia were recorded.
Rectal temperature (RT), respiratory rate (RR), heart rate
(HR), haemoglobin oxygen saturation (OHS), and mean
arterial blood pressure (MBP) were measured before and
20 min after the administration of xylazine or diazepam
and then every 10 min until recovery. RT was recorded
using a digital thermometer and respiratory rate was
counted by watching the movement of either the thoracic
or the abdominal wall. A pulse oximeter (504DX Digital
Oximeter, Criticare Systems Inc., Waukesha, WI, USA)
with a probe attached to the tip of the ear was used to

assess the concentration of OHS and HR. The values of
MBP were indirectly measured by oscillometer (Accutorr
Plus Recorder, Datascope, Datascope Corp., Paramus,
NJ, USA) using a cuff placed around the arm. The depth
of anaesthesia was determined by monitoring various
reflexes including palpebral, corneal, and jaw reflexes. The
onset time and signs of recovery were determined.
2.3. Sampling
Cephalic blood samples (approximately 1–1.5 mL) were
collected from each hamadryas baboon and transferred
to EDTA- and heparin-containing Vacutainer tubes
(Venoject, Leuven, Belgium) immediately before and 20
min after the injection of xylazine or diazepam, 20 and 30
min after the injection of ketamine, and at the onset of and
full recovery from anaesthesia. The blood samples with
EDTA were used to determine the red blood cell (RBC)
and white blood cell (WBC) counts, differential leucocytic
counts (dWBC), packed cell volume (PCV), haemoglobin
concentration (HGB), haematocrit (HCT), and platelets
(PLT) using an automated machine (VetScan HM5,
ABAXIS, Union City, CA, USA). The blood samples with
heparin were used for measurement of concentrations of
oxygen (PO2), carbon dioxide (PCO2), pH, sodium (Na),
potassium (K), calcium (Ca), and lactate immediately in
venous blood using a blood gas analyser (GEM Premier
3000, Instrumentation Laboratory Co., Bedford, MA,
USA). The levels of glucose were measured before and 20
min after the administration of xylazine or diazepam and
then every 10 min until recovery. This test was performed
by using the traditional home blood glucose monitoring
method, which involved pricking the hamadryas baboon’s
finger with a lancet, putting a drop of blood on a test strip,
and then placing the strip into a meter that displays the
blood glucose level.
2.4. Statistical analysis
The data were analysed and comparisons were made
between the two groups with a commercial statistical
software package (SAS version 8, SAS Institute Inc., Cary,
NC, USA). A repeated measures analysis of variance
(ANOVA) was used as the statistical model to evaluate the
differences over time in the dependent variables, including
the parameters of physiological and haematological
functions. Duncan’s test was used to calculate multiple
comparisons. Results were considered significant at P <
0.05.
3. Results
The RR was significantly (P < 0.05) depressed in the DK
hamadryas baboons group (Figure 1A) 10 min following
ketamine administration. The HR and RT significantly
decreased (P < 0.01) during anaesthesia in the hamadryas
baboons belonging to the XK group (Figures 1B and 1C).
The MBP decreased during anaesthesia in both groups
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Figure 1. Changes in (A) respiratory rate, (B) heart rate, (C) body temperature, (D) mean arterial blood pressure (MBP),
(E) oxygen haemoglobin saturation (OHS) and (F) glucose in young hamadryas baboons (n = 6) anaesthetised with
xylazine–ketamine (dotted lines) and diazepam–ketamine (solid lines) at 0 time and 20 min (0, 20 X/D) after xylazine/
diazepam injection and 10, 20, 30, 40, 50, 60, 70, 80, and 90 min after ketamine administration (*indicates significant
values compared to baseline value (these values were obtained before administration of anaesthetic protocols)).

(Figure 1D). The OHS did not significantly (P > 0.2) change
in either group (Figure 1E). Hyperglycaemia was observed
after XK administration, but not after DK (Figure 1F) (P <
0.01). There were significant changes in the levels of PCO2
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between the two groups at 20 min after premedication
injection (P < 0.05) and 20 min after ketamine injection
(P < 0.05). In addition, within the DK group, levels of
PCO2 were significantly increased following diazepam
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and ketamine administration (P < 0.05). Otherwise, no
significant difference was observed in CBC (Tables 1 and
2), blood gases, electrolytes, or lactate level (Tables 3 and
4) between the anaesthesia protocols.
Within 2.5 (±0.4) min following the xylazine injection,
the animals showed signs of decreased spontaneous
activity by sitting on the sternum and sometimes lying
down. Within 2 (±0.5) min of diazepam administration,
the hamadryas baboons were awake, but with some signs
associated with ataxic movement (e.g., falling down, lack
of coordination), minor skin rubbing, and yawning. In
both groups, within 1.5 (±0.9) min postadministration
of ketamine, the hamadryas baboons were lying down,
and the jaw reflex was absent within 3 (±0.6) min. In the

hamadryas baboons of both groups, palpebral and corneal
reflexes disappeared 5 (±0.4) min after the administration
of ketamine (Table 5). The duration of anaesthesia was 40
(±6) and 34 (±4) min for XK and DK, respectively.
The first sign of recovery in the XK hamadryas baboons
appeared 40 (±5) min after the ketamine injection and was
characterised by movement of the tail. Subsequently, the
signs of recovery gradually appeared, with palpebral and
corneal reflexes returning in 45 (±6) min, moving the head
while still lying on the ground in 47 (±6) min, raising the
head in 48 (±2) min, moving the limbs in 50 (±4) min, sitting
on the sternum in 58 (±6) min, and walking in a creeping
posture 60 (±5) min after ketamine administration.
Urination was observed during the recovery period in 3/6

Table 1. Mean (±SEM) values of complete blood count in young hamadryas baboons (n = 6) after xylazine and ketamine administration.
Time
Parameter

Before
injection (T0)

20 min after xylazine
injection (T1)

20 min after ketamine
injection (T2)

30 min after ketamine
injection (T3)

At the beginning
of recovery (T4)

At full
recovery (T5)

WBC (×109/L)

9.3 (±0.3)

9.4 (±1.3)

10.7 (±1.7)

9.3 (±1.3)

9.2 (±2.3)

9.3 (±2.6)

Lymphocytes (%)

58.4 (±5.3)

56.7 (±3.6)

55.6 (±2.3)

56.8 (±1.8)

59.3 (±2.6)

57.4 (±3.8)

Monocytes (%)

1.5 (±0.3)

0.9 (±0.4)

1.1 (±0.3)

0.9 (±0.7)

0.6 (±0.3)

0.7 (±0.2)

Neutrophils (%)

39.0 (±3.3)

41.2 (±6.3)

42.1 (±7.6)

41.5 (±10.4)

39.7 (±13.2)

40.4 (±7.9)

Eosinophils (%)

1.1 (±1)

1 (±0.5)

1.2 (±0.5)

0.7 (±0.2)

0.4 (±0.2)

1.4 (±0.4)

Basophils (%)

0 (±0)

0.2 (±0.07)

0 (±0)

0.1 (±0.05)

0 (±0)

0.1 (±0.03)

RBCs (×1012/L)

6.15 (±0.6)

5.9 (±0.8)

5.4 (±0.5)

5.8 (±0.6)

6.51 (±0.8)

6.38 (±0.9)

HGB (g/dL)

12.3 (±1.1)

11.5 (±1.2)

11.1 (±0.9)

12.4 (±1.5)

13.3 (±2.3)

13.8 (±1.7)

HCT (%)

40.9 (± 3)

36.9 (±4.3)

36.6 (±7.2)

37.3 (±5.6)

39 (±6.3)

38.1 (±6.4)

461 (±30)

420 (±37)

380 (±39)

340 (±29)

445 (± 32)

456 (± 45)

Platelets (×10 /L)
9

White blood cell; Red blood cells; Haemoglobin concentration; Haematocrit.
Table 2. Mean (±SEM) values of complete blood count in young hamadryas baboons (n = 6) after diazepam and ketamine administration.
Time
Parameter

Before
injection (T0)

20 min after diazepam 20 min after ketamine 30 min after ketamine
injection (T1)
injection (T2)
injection (T3)

At the beginning of
recovery (T4)

At full recovery
(T5)

WBC (×109/L)

9.4 (±0.3)

9.6 (±1.8)

9.6 (±3.2)

10.2 (±5.2)

11.4 (±3.4)

10.4 (±3.2)

Lymphocytes (%)

60.1 (±5)

56.4 (±7.3)

54.8 (±10)

57.7 (±6)

57.6 (±9.2)

58.2 (±9.6)

Monocytes (%)

1.2 (±2)

0.9 (±0.3)

1.4 (±0.6)

1.1 (±0.3)

1.2 (±0.2)

1.3 (±0.6)

Neutrophils (%)

38.7 (±3)

41.3 (±10.3)

43.5 (±9.2)

40.2 (±7.8)

40.1 (±10.2)

39.5 (±12.2)

Eosinophils (%)

0 (±0)

1.2 (±0.7)

0.2 (±0.1)

1 (±0.6)

1.1 (±0.5)

1.0 (±0.4)

Basophils (%)

0 (±0)

0.2 (±0.1)

0.1 (±0.05)

0 (±0)

0 (±0)

0 (±0)

RBCs (×1012/L)

6.81 (±0.4)

6.51 (±0.3)

5.3 (±1.2)

6.4 (±1.3)

6.7 (±1.2)

6.8 (±1.1)

HGB (g/dL)

12.7 (±0.2)

12.6 (±0.6)

11.6 (±0.4)

12.2 (±3.2)

12.7 (±0.8)

12.7 (±1.5)

HCT (%)

42.8 (±4.2)

37.2 (±3)

31.4 (±7.2)

42.4 (±5.3)

42.5 (±6.3)

42.6 (±3.3)

Platelets (×109/L)

450 (±20)

400 (±30)

300 (±30)

315 (±35)

401 (±30)

405 (±34)

White blood cell; Red blood cells; Haemoglobin concentration; Haematocrit.
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Table 3. Mean (±SEM) values of venous blood gases, electrolytes, and lactate in young hamadryas baboons (n = 6) after xylazine and
ketamine administration.
Time
Parameter

Before
injection (T0)

20 min after xylazine
injection (T1)

20 min after ketamine
injection (T2)

30 min after ketamine
injection (T3)

At the beginning of
recovery (T4)

At full
recovery (T5)

pH (mol/L)

7.50 (±0.3)

7.50 (±1.2)

7.52 (±1.0)

7.47 (±1.4)

7.51 (±0.3)

7.51 (±1.1)

PCO2 (mmHg)

23 (±2.6)

25 (±1.6)

21 (±1.3)

30 (±3.5)

21 (±1.6)

22 (±1.8)

PO2 (mmHg)

50 (±20)

53 (±12)

61 (±11)

55 (±15)

53 (±13)

53 (±14)

Na (mmol/L)

148 (±2)

149.5 (±1)

148 (±2)

149 (±0.8)

149 (±0.6)

149 (±1.9)

K (mmol/L)

4.3 (±1)

4.3 (±0.2)

4.4 (±2)

4.1 (±0.7)

4.2 (±0.2)

4.1 (±0.2)

Ca (mmol/L)

0.95 (±0.5)

0.84 (±0.4)

0.93 (±0.5)

1 (±0.1)

0.95 (±0.2)

0.95 (±0.3)

Lactate (mmol/L)

4.3 (±0.2)

3.9 (±0.3)

4.0 (±0.4)

3.7 (±0.3)

3.8 (±0.3)

4.0 (±0.4)

PCO2: Concentration of carbon dioxide; PO2: Concentration of oxygen; Na: Sodium; K: Potassium; Ca: Calcium. Results were considered
significant at P < 0.05.
Table 4. Mean (±SEM) values of venous blood gases, electrolytes, and lactate in young hamadryas baboons (n = 6) after diazepam and
ketamine administration.
Time
Parameter

Before injection
(T0)

20 min after diazepam
injection (T1)

20 min after ketamine 30 min after ketamine At the beginning At full recovery
injection (T2)
injection (T3)
of recovery (T4) (T5)

pH (mol/L)

7.50 (±0.3)

7.47 (±0.4)

7.47 (±0.5)

7.46 (±0.2)

7.48 (±0.2)

7.50 (±0.5)

PCO2 (mmHg)

24 (±0.5)

35 (±2.3)*

36.5 (±4.2)*

35.3 (±3)*

25.6 (±2.2)

25.2 (±2.6)

PO2 (mmHg)

50 (±12)

47 (±10)

55 (±13)

53 (±10)

53 (±12)

50 (±11)

Na (mmol/L)

149 (±.5)

149 (±1)

148 (±1.2)

148 (±2)

150 (±3.2)

149 (±2.2)

K (mmol/L)

4.3 (±0.2)

4.3(±0.5)

4.3 (±0.3)

4.5 (±1.6)

4.5 (±0.8)

4.4 (±0.7)

Ca (mmol/L)

1 (±0.3)

0.95 (±0.5)

1 (±0.3)

0.95 (±0.4)

0.94 (±0.5)

0.96 (±0.6)

Lactate (mmol/L)

4.4 (±0.6)

3.8 (±0.4)

3.6 (±0.4)

3.5 (±0.3)

3.6 (±0.4)

3.9 (±0.3)

PCO2: Concentration of carbon dioxide; PO2: Concentration of oxygen; Na: Sodium; K: Potassium; Ca: Calcium. Results were considered
significant at P < 0.05.
Table 5. Parameters of anaesthesia in young hamadryas baboons after administration of xylazine–ketamine and
diazepam–ketamine.
Parameters of anaesthesia

Xylazine–ketamine

Diazepam–ketamine

Time of disappearance of jaw reflex

3 (±0.6) min

3 (±0.6) min

Time of disappearance of eye reflex

5 (±0.4) min

5 (±0.4) min

Beginning of recovery

40 (±5)

34 (±6)

Full recovery

91 (±10) min after ketamine injection

60 (±10) min after ketamine injection

Duration of anaesthesia

40 (±6)

34 (±4)

of the hamadryas baboons in the XK group 43 (±7) min
postketamine injection. Full recovery occurred 91 (±10)
min after ketamine administration.
In the DK group, the first sign of recovery was seen
34 (±6) min after the ketamine injection. This was
characterised by either moving the head and hands together
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(3/6 hamadryas baboons) or by minor jerking over the
entire body (3/6 hamadryas baboons). The palpebral and
corneal reflexes returned 36 (±5) min after the ketamine
injection. Afterwards, the hamadryas baboons suddenly
stood up and then fell down while trying to walk 38 (±6)
min after the ketamine injection. Urination was observed
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during recovery in 2/6 hamadryas baboons 40 (± 4) min
after administration of ketamine. Full recovery occurred
60 (±10) min after the administration of ketamine.
Highly significant hyperglycaemia (P < 0.05) was
observed in all hamadryas baboons when using the XK
combination and, on the other hand, the administration
of DK did not significantly (P > 0.05) alter the levels of
sugar in the blood. A significant elevation (P < 0.05) in
the concentration of PCO2 was seen in the DK group
after ketamine administration (Table 4). Otherwise, no
significant difference was observed in CBC, electrolytes,
or lactate level between the anaesthesia protocols.
4. Discussion
This study was conducted to analyse the effects of
anaesthesia with XK and DK on the physiological and
haemodynamic parameters of young baboons. Baboons
are frequently used as experimental animal models for a
wide variety of human research (5–8). In fact, the baboon
is considered an ideal experimental model because of
genetic similarity to humans of approximately 89%. They
have an immune system similar to that of humans and
are relatively large in size, and thus capable of providing
ample fluid and tissue samples (7,20). In the present
study, both XK and DK produced a depth of anaesthesia
and analgesia in the young baboons sufficient for surgical
procedures. The duration of anaesthesia was longer (40
min) and recovery was smoother for XK compared to DK
(34 min). Minor skin rubbing was observed in baboons
after the DK regimen was applied. This might be due to
the intramuscular injection of the diazepam, which is
usually painful in nonhuman primates (14).
This study found a significant reduction in the
respiratory rates of hamadryas baboons in the DK group.
Respiratory depression has been reported in humans
following diazepam administration (21–24). In children
with seizures, the overall incidence of respiratory
depression
following
diazepam
administration
intravenously, rectally, or both was 20%, 5%, and 9%,
respectively (25,26). Respiratory depression has also been
reported in adult humans following the use of diazepam
(27). It has been thought that diazepam causes respiratory
depression due to direct suppression of the central
respiratory drive (22). In addition, benzodiazepines
including diazepam exhibit some muscular relaxation
properties capable of depressing the respiratory muscle
strength (22) and causing CO2 retention (24). The
levels of CO2 in the present study were significantly
higher in the DK group 20 min following diazepam
and ketamine administration. Even though ketamine
stimulates respiration in various species, diazepaminduced respiratory depression might have masked this
stimulation in the DK group.

In the XK group, the HR significantly decreased
20 min after the injection of xylazine. This study is in
agreement with other studies using nonhuman primates
(28) and other species (29–33). It has been reported
that xylazine-induced bradycardia is associated with
a decreased outflow of sympathetic nervous system
impulses to the periphery and with increased vagal
activity (34). In the present study, the levels of HR
gradually increased after the administration of ketamine,
but were not enough to show significant improvement.
In most species, including hamadryas baboons, the
administration of ketamine stimulates HR (18,32,35).
In the present study, the continuous reduction of HR
encountered in the XK group indicated that xylazine
overrides the stimulatory effects of ketamine.
Body temperature is regulated by both the central
and the peripheral thermoregulatory mechanisms.
The rectal temperature was a reliable, noninvasive
approximation of the internal core body temperature of
the young baboons. Hypothermia was observed in both
groups; however, it was significant in the XK group.
Similar results have been reported in primates (36) and
other animals including rats (37,38), rabbits (39), cattle
(40), and goats (41). Both xylazine and ketamine have
been reported as producing a hypothermic response
(17,42–45). The central control of body temperature
is located in the hypothalamus, and α-2 agonistsinduced hypothermia is associated with a presynaptic
inhibition of noradrenaline (46,47). The blockade of
N-methyl-D-aspartate (NMDA) receptors is credited as
being the mechanism by which ketamine produces the
hypothermic response (44,48). Others have suggested
that ketamine-produced hypothermia is due to the
release of serotonin in the hypothalamus (49).
Highly significant hyperglycaemia was observed in
all hamadryas baboons when using the XK combination.
Xylazine-induced hyperglycaemia has been reported
previously in various species, including humans (50),
rhesus hamadryas baboons (51), rats (52), mice (53),
dogs (54,55), cats (56), horses (57), and cattle (58–60).
It has been stated that the acute hyperglycaemic effect of
XK administration is associated with decreased plasma
levels of insulin, adrenocorticotropic hormone (ACTH),
and corticosterone and increased levels of glucagon and
growth hormone (52,61). Recent studies have shown
that xylazine can cause hyperglycaemia in nonhuman
primates with no significant alterations in blood insulin
and glucagon. The stimulation of α2-adrenoceptors and
subsequent decreasing tissue sensitivity to insulin lead
to the reduction of tissue glucose uptake and utilisation
(51). On the other hand, the administration of DK did
not significantly alter the levels of sugar in the blood.
In fact, oral diazepam has been used in humans to
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attenuate the hyperglycaemic response resulting from
surgical stress (62).
In conclusion, major complications including
bradycardia, hypothermia, and hyperglycaemia should be
considered when anaesthetising young hamadryas baboons
with a combination of xylazine–ketamine. However, no
complications other than bradypnea and hypercapnia
should be expected when immobilising young hamadryas
baboons with diazepam–ketamine. Therefore, it was

concluded that anaesthesia using diazepam–ketamine is
better than that using xylazine–ketamine.
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